Form 8-K - Current report:
SEC Accession No. 0001585364-24-000111
Filing Date
2024-08-02
Accepted
2024-08-02 06:44:35
Documents
16
Period of Report
2024-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prgo-20240802.htm   iXBRL 8-K 50015
2 EX-99.1 cy24q2ex991pressrelease.htm EX-99.1 986165
7 perrigoimagenewa.jpg GRAPHIC 18151
  Complete submission text file 0001585364-24-000111.txt   1321111

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20240802.xsd EX-101.SCH 3880
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20240802_def.xml EX-101.DEF 8180
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20240802_lab.xml EX-101.LAB 33648
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20240802_pre.xml EX-101.PRE 20215
19 EXTRACTED XBRL INSTANCE DOCUMENT prgo-20240802_htm.xml XML 7031
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 241168795
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)